RISP Search - Regulatory Information Discovery

Type	Title & Description	Details	Country	Status
Trial	Trial of a Novel Nutritional Supplement for Pregnant Women to Prevent Low Birth Weight Biologics - European Union Humanitarian Aid - Action Contre la Faim Madagascar	Mfr: European Union Humanitarian Aid Applicant: Action Contre la Faim Madagascar Sponsor: European Union Humanitarian Aid Cat: Biologics Type: Biologics 📅 Sep 18, 2024	● Madagascar	Recruiting
Trial	A multi-country, multi-centre, two arm, parallel, double blind, placebo controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low resource countries to improve newborn out Biologics - World Health Organization - Dr Idowu Ayede	Mfr: World Health Organization Applicant: Dr Idowu Ayede Sponsor: World Health Organization Cat: Biologics Type: Biologics	—	Approved
Trial	A multi-country, multi-centre, two arm, parallel, double blind, placebo- controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low resource countries to improve newborn out Drug - Department of Reproductive Health & Research, World Health Organisation - Dr Adejumoke Idowu Ayede	Mfr: Department of Reproductive Health & Research, World Health Organisation Applicant: Dr Adejumoke Idowu Ayede Sponsor: Department of Reproductive Health & Research, World Health Organisation Cat: Drug Type: Drug	—	Approved
Trial	A multi-country, multi-centre, two-arm, parallel, double blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low resource countries to improve newborn out Drug - World Health Organization - Prof Oluwafemi Kuti	Mfr: World Health Organization Applicant: Prof Oluwafemi Kuti Sponsor: World Health Organization Cat: Drug Type: Drug	—	Approved
Trial	A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outc Drug - World Health Organization - Prof Olufemi Kuti	Mfr: World Health Organization Applicant: Prof Olufemi Kuti Sponsor: World Health Organization Cat: Drug Type: Drug	—	Approved
Trial	A Multicentre, Double blind, Randomized, parallel group, clinical trial to compare the sexual pleasure, performance, acceptability and safety of Graphene incorporated natural rubber latex condoms and natural rubber latex compounds in healthy humans. Vaccine - The George Institute for Global Health, - Xcene Research Ltd	Mfr: The George Institute for Global Health, Applicant: Xcene Research Ltd Sponsor: The George Institute for Global Health, Cat: Vaccine Type: Vaccine	—	Approved
Trial	A Phase 2/3 Trial of a New Oral Cholera Vaccine in High-Risk Populations Vaccine - Gavi, the Vaccine Alliance, International Vaccine Institute - African Medical Research Foundation (AMREF) Somalia	Mfr: Gavi, the Vaccine Alliance, International Vaccine Institute Applicant: African Medical Research Foundation (AMREF) Somalia Sponsor: Gavi, the Vaccine Alliance, International Vaccine Institute Cat: Vaccine Type: Vaccine 📅 Aug 30, 2024	● Somalia	Active
Trial	A phase III, randomised, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering v Drug - Department of Reproductive Health & Research, World Health Organization - Dr Bukola Fawole	Mfr: Department of Reproductive Health & Research, World Health Organization Applicant: Dr Bukola Fawole Sponsor: Department of Reproductive Health & Research, World Health Organization Cat: Drug Type: Drug	—	Approved
Trial	A phase III, randomized, double blind, active, controlled, multi national, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of post partum haemorrhage during the third stage of labour in women delivering Drug - Department of Reproductive Heath & Research, World Health Organization - Dr Bukola Fawole	Mfr: Department of Reproductive Heath & Research, World Health Organization Applicant: Dr Bukola Fawole Sponsor: Department of Reproductive Heath & Research, World Health Organization Cat: Drug Type: Drug	—	Approved
Trial	A Phase IIIB/IV Randomized Open-label Trial Comparing Dolutegravir with Predetermined Nucleosides Versus Recommended Standard of Care ART R regimens in Patients with HIV-1 Infection Failing First Line Therapy Drug - University of New South Wales - The Institute of Human Virology-IHVN	Mfr: University of New South Wales Applicant: The Institute of Human Virology-IHVN Sponsor: University of New South Wales Cat: Drug Type: Drug	—	Approved
Trial	A randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events Vaccine - McMaster University - Prof Kamilu M. Karaye	Mfr: McMaster University Applicant: Prof Kamilu M. Karaye Sponsor: McMaster University Cat: Vaccine Type: Vaccine	—	Approved
Trial	An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel group, randomized controlled trial to determine the effect of more intensive blood pressure control provided by a fixed low-dose combination Drug - The George Institute for Global Health - Xcene Research Ltd	Mfr: The George Institute for Global Health Applicant: Xcene Research Ltd Sponsor: The George Institute for Global Health Cat: Drug Type: Drug	—	Approved
Trial	ClustEr randomised Trial of sterile glove and instrument change at the time of wound closure to reduce surgical site infection in low and middle income counties (LMICs) Procedure - University of Birmingham - NIHR GSU Lagos Hub, College of Medicine, University of lagos	Mfr: University of Birmingham Applicant: NIHR GSU Lagos Hub, College of Medicine, University of lagos Sponsor: University of Birmingham Cat: Procedure Type: Procedure	—	Approved
Trial	Implementation Trial of a New Maternity Care Bundle to Reduce Postpartum Hemorrhage Procedure - UNFPA, University of Montreal - UNFPA Burundi	Mfr: UNFPA, University of Montreal Applicant: UNFPA Burundi Sponsor: UNFPA, University of Montreal Cat: Procedure Type: Procedure 📅 Feb 06, 2026	—	Active
Trial	Investigation of Rheumatic AF Treatment Using Vitamin K antagonists, Rivaroxaban or Aspirin Studies (INVICTUS Trials) Drug - Hamilton Health Science, Hamilton, Ontario, Canada - Dr. Okechwukwu S. Ogah	Mfr: Hamilton Health Science, Hamilton, Ontario, Canada Applicant: Dr. Okechwukwu S. Ogah Sponsor: Hamilton Health Science, Hamilton, Ontario, Canada Cat: Drug Type: Drug	—	Approved
Trial	Pragmatic multicentre Factorial randomized controlled trial testing measures of reducing surgical site infection in low and middle income countries Procedure - University of Birmingham - NIHR GSU Lagos Hub, College of Medicine, University of Lagos	Mfr: University of Birmingham Applicant: NIHR GSU Lagos Hub, College of Medicine, University of Lagos Sponsor: University of Birmingham Cat: Procedure Type: Procedure	—	Approved
Trial	Primary Prevention of Stroke in Nigerian Children with Sickle Cell Disease in Sub Saharan Africa II: a partial double blind randomized Phase III clinical trial Drug - Vanderbilt University School of Medicine - Aminu Kano Teaching Hospital	Mfr: Vanderbilt University School of Medicine Applicant: Aminu Kano Teaching Hospital Sponsor: Vanderbilt University School of Medicine Cat: Drug Type: Drug	—	Approved
Trial	Tranexamic acid for the treatment of gastrointestinal bleeding: an international randomised, double blind placebo control trial Drug - London School of Hygiene & Tropical Medicine - Prof. Bukonla Fawole	Mfr: London School of Hygiene & Tropical Medicine Applicant: Prof. Bukonla Fawole Sponsor: London School of Hygiene & Tropical Medicine Cat: Drug Type: Drug	—	Approved
Trial	Traxenamic acid for reducing postpartum bleeding in women with anaemia: an international, randomized, double blind, placebo controlled trial.b Drug - London School of Hygiene and Tropical Medicine - Prof Oladapo Olayemi	Mfr: London School of Hygiene and Tropical Medicine Applicant: Prof Oladapo Olayemi Sponsor: London School of Hygiene and Tropical Medicine Cat: Drug Type: Drug	—	Approved
Trial	Traxenamic acid for the treatment of postpartum haemorrhage: An international, randomised, double blind placebo controlled trial Drug - London School of Hygiene & Tropical Medicine - Prof Bukola Fawole	Mfr: London School of Hygiene & Tropical Medicine Applicant: Prof Bukola Fawole Sponsor: London School of Hygiene & Tropical Medicine Cat: Drug Type: Drug	—	Approved
Trial	Traxenamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placembo controlled trial Drug - London School of Hygiene & Tropical Medicine - Prof. Bukola Fawole	Mfr: London School of Hygiene & Tropical Medicine Applicant: Prof. Bukola Fawole Sponsor: London School of Hygiene & Tropical Medicine Cat: Drug Type: Drug	—	Approved
Trial	A Phase 2b Trial of a Therapeutic HIV Vaccine in Adults Initiating Antiretroviral Therapy in Malawi Vaccine - International AIDS Vaccine Initiative (IAVI) - Kamuzu University of Health Sciences	Mfr: International AIDS Vaccine Initiative (IAVI) Applicant: Kamuzu University of Health Sciences Sponsor: International AIDS Vaccine Initiative (IAVI) Cat: Vaccine Type: Vaccine 📅 Feb 06, 2026	—	Not yet recruiting
Trial	A Phase III Randomized Trial of Artemisinin-based Combination Therapy for Uncomplicated Malaria in Sub-Saharan Africa Drug - World Health Organization - University of Lagos Teaching Hospital	Mfr: World Health Organization Applicant: University of Lagos Teaching Hospital Sponsor: World Health Organization Cat: Drug Type: Drug 📅 Feb 06, 2026	● Nigeria	Recruiting
Trial	A Phase III Trial of a New Antimalarial Drug in Burundi Drug - Burundi Ministry of Health, WHO - Burundi Ministry of Health	Mfr: Burundi Ministry of Health, WHO Applicant: Burundi Ministry of Health Sponsor: Burundi Ministry of Health, WHO Cat: Drug Type: Drug 📅 Feb 06, 2026	—	Recruiting
Trial	A Randomized Controlled Trial of a New Anthelmintic Drug for Soil-Transmitted Helminthiasis Drug - Swiss Tropical and Public Health Institute - Madagascar Institute of Public Health	Mfr: Swiss Tropical and Public Health Institute Applicant: Madagascar Institute of Public Health Sponsor: Swiss Tropical and Public Health Institute Cat: Drug Type: Drug 📅 Nov 14, 2024	● Madagascar	Recruiting
Trial	A Randomized Controlled Trial of a New Hemostatic Dressing for Trauma Wounds in Conflict-Affected Settings in South Sudan Device - U.S. Army Medical Research and Development Command - Médecins Sans Frontières (MSF)	Mfr: U.S. Army Medical Research and Development Command Applicant: Médecins Sans Frontières (MSF) Sponsor: U.S. Army Medical Research and Development Command Cat: Device Type: Device 📅 Feb 06, 2026	—	Not yet recruiting
Trial	A Randomized Controlled Trial of a New Wound Dressing for Conflict-Related Injuries Device - Médecins Sans Frontières Operational Center Brussels - Médecins Sans Frontières (MSF) Somalia	Mfr: Médecins Sans Frontières Operational Center Brussels Applicant: Médecins Sans Frontières (MSF) Somalia Sponsor: Médecins Sans Frontières Operational Center Brussels Cat: Device Type: Device 📅 Jan 12, 2025	● Somalia	Recruiting
Trial	A Randomized Trial of Two Antiretroviral Therapy Regimens in Burundi Drug - National AIDS Control Program Burundi, PEPFAR - National AIDS Control Program Burundi	Mfr: National AIDS Control Program Burundi, PEPFAR Applicant: National AIDS Control Program Burundi Sponsor: National AIDS Control Program Burundi, PEPFAR Cat: Drug Type: Drug 📅 Feb 06, 2026	—	Recruiting
Trial	A Trial of a Novel Nutritional Supplement for Moderate Acute Malnutrition (MAM) in Children Under Five in South Sudan Biologics - Washington University in St. Louis - World Food Programme (WFP)	Mfr: Washington University in St. Louis Applicant: World Food Programme (WFP) Sponsor: Washington University in St. Louis Cat: Biologics Type: Biologics 📅 Feb 06, 2026	—	Active, not recruiting
Trial	A Trial of Ivermectin Mass Drug Administration for Malaria Control in Southern Malawi (IMDA-MW) Drug - National Institutes of Health (NIH) - Michigan State University - Malawi Program	Mfr: National Institutes of Health (NIH) Applicant: Michigan State University - Malawi Program Sponsor: National Institutes of Health (NIH) Cat: Drug Type: Drug 📅 Feb 06, 2026	—	Enrolling by invitation
Trial	A Trial of New First-line Antiretroviral Therapy Regimens in Malawi (NEWFIRST) Drug - Ministry of Health, Malawi - Lighthouse Trust	Mfr: Ministry of Health, Malawi Applicant: Lighthouse Trust Sponsor: Ministry of Health, Malawi Cat: Drug Type: Drug 📅 Feb 06, 2026	—	Recruiting
Trial	Community-Based Randomized Trial of a New Water Purification Solution for the Prevention of Diarrheal Diseases Device - Centers for Disease Control and Prevention (CDC) - Oxfam	Mfr: Centers for Disease Control and Prevention (CDC) Applicant: Oxfam Sponsor: Centers for Disease Control and Prevention (CDC) Cat: Device Type: Device 📅 Feb 06, 2026	—	Recruiting
Trial	Investigation of the Potential Beneficial Effects of Cannabidiol in the management of Tardive Dyskinesia using Animal Studies and a clinical trial Drug - South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University - Dr Jaiyeola Abiola Kajero	Mfr: South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University Applicant: Dr Jaiyeola Abiola Kajero Sponsor: South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University Cat: Drug Type: Drug	—	Rejected
Trial	malai Clinical Trial - Phase III vacine - Global Health Foundation - Test Pharmaceuticals Ltd	Mfr: Global Health Foundation Applicant: Test Pharmaceuticals Ltd Sponsor: Global Health Foundation Cat: vacine Type: vacine 📅 Dec 15, 2025	—	Submitted
Trial	Phase 2b Trial of a Bivalent HPV Vaccine in Adolescent Girls Vaccine - Gavi, the Vaccine Alliance - Ministry of Public Health of Madagascar	Mfr: Gavi, the Vaccine Alliance Applicant: Ministry of Public Health of Madagascar Sponsor: Gavi, the Vaccine Alliance Cat: Vaccine Type: Vaccine 📅 May 15, 2024	● Madagascar	Recruiting
Trial	Phase II Trial of a Repurposed Drug for Multidrug-Resistant Tuberculosis Drug - Médecins Sans Frontières - Médecins Sans Frontières	Mfr: Médecins Sans Frontières Applicant: Médecins Sans Frontières Sponsor: Médecins Sans Frontières Cat: Drug Type: Drug 📅 Feb 06, 2026	—	Recruiting
Trial	Test Clinical Trial - Phase III Drug - Global Health Foundation - Test Pharmaceuticals Ltd	Mfr: Global Health Foundation Applicant: Test Pharmaceuticals Ltd Sponsor: Global Health Foundation Cat: Drug Type: Drug 📅 Dec 15, 2025	—	Submitted
Trial	Evaluation of a Rapid Diagnostic Algorithm for Surgical Site Infections Procedure - European and Developing Countries Clinical Trials Partnership - Hospital Sanatório de Luanda	Mfr: European and Developing Countries Clinical Trials Partnership Applicant: Hospital Sanatório de Luanda Sponsor: European and Developing Countries Clinical Trials Partnership Cat: Procedure Type: Procedure 📅 Feb 06, 2026	● Angola	Recruiting

🔍 Search RISP Database

📍 Results by Country

Premium Service